SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-001345
Filing Date
2021-01-11
Accepted
2021-01-11 17:06:56
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3956
  Complete submission text file 0000899243-21-001345.txt   5422
Mailing Address C/O 235 EAST 42ND ST. NEW YORK NY 10017
Business Address
Mckernan Ruth (Reporting) CIK: 0001531340 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 21521509

Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations